These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21049134)

  • 1. Tandem free-radical addition/substitution chemistry and its application to the preparation of novel AT1 receptor antagonists.
    Staples MK; Grange RL; Angus JA; Ziogas J; Tan NP; Taylor MK; Schiesser CH
    Org Biomol Chem; 2011 Jan; 9(2):473-9. PubMed ID: 21049134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenosartans: novel selenophene analogues of milfasartan and eprosartan.
    Grange RL; Ziogas J; North AJ; Angus JA; Schiesser CH
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1241-4. PubMed ID: 18191398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of novel selenapenams and selenacephems by nucleophilic and radical chemistry involving benzyl selenides.
    Carland MW; Martin RL; Schiesser CH
    Org Biomol Chem; 2004 Sep; 2(18):2612-8. PubMed ID: 15351825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of 2,3-dihydroselenolo[2,3-b]pyridines and related compounds by free-radical means.
    Fenner T; White JM; Schiesser CH
    Org Biomol Chem; 2006 Feb; 4(3):466-74. PubMed ID: 16446804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taming the free radical shrew - learning to control homolytic reactions at higher heteroatoms.
    Schiesser CH
    Chem Commun (Camb); 2006 Oct; (39):4055-65. PubMed ID: 17024249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual action molecules: bioassays of combined novel antioxidants and angiotensin II receptor antagonists.
    Jani NV; Ziogas J; Angus JA; Schiesser CH; Macdougall PE; Grange RL; Wright CE
    Eur J Pharmacol; 2012 Nov; 695(1-3):96-103. PubMed ID: 22975712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenochromanes via tandem homolytic addition/substitution chemistry.
    Staples MK; Schiesser CH
    Chem Commun (Camb); 2010 Jan; 46(4):565-7. PubMed ID: 20062863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.
    Naik P; Murumkar P; Giridhar R; Yadav MR
    Bioorg Med Chem; 2010 Dec; 18(24):8418-56. PubMed ID: 21071232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insight on the activity of type 1 angiotensin II peptide antagonists using MD simulations.
    Preto MA; Melo A; Rodrigues LM; Maia HL; Ramos MJ
    J Phys Chem B; 2008 Oct; 112(43):13620-8. PubMed ID: 18834172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validated quantitation of angiotensin II receptor antagonists (ARA-II) in human plasma by liquid-chromatography-tandem mass spectrometry using minimum sample clean-up and investigation of ion suppression.
    Ferreirós N; Dresen S; Alonso RM; Weinmann W
    Ther Drug Monit; 2007 Dec; 29(6):824-34. PubMed ID: 18043483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short synthesis of lennoxamine using a radical cascade.
    Taniguchi T; Iwasaki K; Uchiyama M; Tamura O; Ishibashi H
    Org Lett; 2005 Sep; 7(20):4389-90. PubMed ID: 16178540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists.
    Xu JY; Zeng Y; Ran Q; Wei Z; Bi Y; He QH; Wang QJ; Hu S; Zhang J; Tang MY; Hua WY; Wu XM
    Bioorg Med Chem Lett; 2007 May; 17(10):2921-6. PubMed ID: 17412584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ab initio study of AT2 antagonists.
    Jain S; Yadav A
    Chem Biol Drug Des; 2008 Mar; 71(3):271-7. PubMed ID: 18248348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of heteroarenes using cascade radical cyclisation via iminyl radicals.
    Bowman WR; Cloonan MO; Fletcher AJ; Stein T
    Org Biomol Chem; 2005 Apr; 3(8):1460-7. PubMed ID: 15827642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Route to 2,3-Substituted Benzo[b]thiophenes via Intramolecular Radical Cyclization.
    Singh PP; Yadav AK; Ila H; Junjappa H
    J Org Chem; 2009 Aug; 74(15):5496-501. PubMed ID: 19572579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological properties of angiotensin II receptor antagonists.
    Timmermans PB
    Can J Cardiol; 1999 Nov; 15 Suppl F():26F-8F. PubMed ID: 10579749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of novel selenopenams by intramolecular homolytic substitution.
    Carland MW; Schiesser CH
    Molecules; 2004 May; 9(6):466-71. PubMed ID: 18007446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffolds.
    Cappelli A; Pericot Mohr Gl; Giuliani G; Galeazzi S; Anzini M; Mennuni L; Ferrari F; Makovec F; Kleinrath EM; Langer T; Valoti M; Giorgi G; Vomero S
    J Med Chem; 2006 Nov; 49(22):6451-64. PubMed ID: 17064065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward pyridine-fused selenium-containing antioxidants.
    Fenner T; Schiesser CH
    Molecules; 2004 May; 9(6):472-9. PubMed ID: 18007447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethylzinc-initiated radical reactions.
    Akindele T; Yamada K; Tomioka K
    Acc Chem Res; 2009 Feb; 42(2):345-55. PubMed ID: 19113862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.